Why Straumann Implants Are the Gold Standard

Straumann has been placing implants and publishing outcomes since the 1970s, in collaboration with academic institutions rather than only in-house. The result is one of the largest bodies of independent, long-term clinical literature in implant dentistry — thousands of studies, including prospective follow-up out to ten, fifteen, and twenty years.

That matters because implant survival is a long game. A new system can show excellent one-year results and still perform poorly at fifteen, and there is no way to know in advance. When a surgeon places an implant intended to last decades, the existence of twenty-year data on that specific system is not a marketing point; it is the only real evidence available.

Reported survival rates for Straumann implants sit consistently in the high nineties at ten years across a range of indications, including compromised sites.

Osseointegration happens at the implant surface, and surface texture and chemistry determine how quickly and how well bone cells attach.

Straumann's SLA surface is sandblasted and acid-etched to create roughness at both the micro and nano scale, giving bone-forming cells a surface to grip. SLActive takes it further: the implant is manufactured and stored in a sealed liquid environment so the surface remains chemically active and hydrophilic rather than becoming contaminated by atmospheric carbon.

A hydrophilic surface wets immediately with blood on placement, which accelerates protein adsorption and cell attachment. In practical terms, integration timelines are shortened — often from around twelve weeks to as little as three to four in favorable sites — and integration is more predictable in compromised conditions: grafted bone, diabetic patients, smokers, and immediate placement into extraction sockets.

For patients, that means less waiting and a better margin of safety in exactly the cases where the margin is thin.

Conventional implants are commercially pure titanium. Roxolid is a titanium-zirconium alloy that is substantially stronger in fatigue.

The clinical consequence is dimensional. A narrower implant made from a stronger alloy carries the load of a wider conventional implant, which allows implants in sites too narrow for a standard diameter — thin lower incisor regions, spaces between adjacent teeth, and ridges that would otherwise require augmentation first.

That is a direct patient benefit: in some cases it converts a plan requiring a bone graft and months of additional healing into a single-stage placement.

This consideration is invisible at the time of surgery and decisive later. Implant restorations need service. Screws loosen, abutments need replacing, crowns wear out, and prosthetics get remade.

Every one of those operations requires the correct component for the specific implant system in your jaw. If that system's manufacturer has been acquired, discontinued the line, or gone out of business — which happens regularly among smaller and discount systems — the parts may simply not exist. Patients in that situation sometimes face removing an otherwise healthy, integrated implant because nothing can be attached to it.

Straumann is one of the largest and most established implant manufacturers in the world, with a long record of maintaining backward compatibility. An implant placed today is very likely to be serviceable decades from now, anywhere in the world.

Add rigorous manufacturing tolerances — connection precision determines whether bacteria can colonize the implant-abutment interface, which is a driver of peri-implant bone loss — and the case is straightforward. The implant is the part of the treatment that is meant to be permanent. It is the wrong place to economize, and it is why Diamond Arch does not.

If you are weighing two implant proposals with a meaningful price difference, ask three specific questions. Which implant system is being placed, and how long has that system been on the market with published follow-up? Is the surface treatment hydrophilic, and what integration timeline is being planned as a result? And will replacement components for that system be obtainable in fifteen years?

Those questions are answerable, and the answers explain most price gaps in implant dentistry. They also separate the part of the fee that reflects materials and planning from the part that reflects nothing in particular.

At Diamond Arch the system and the plan are both shown to you in writing before treatment begins, including which implant, which diameter and length, and where it will be placed on your own scan.